Health Stocks in Motion
Shares of Affymetrix (AFFX) were among the worst-performing health-related stocks Friday, falling 19% after the company posted second-quarter results that fell short of expectations and warned that third-quarter results would be below forecasts as well.
The biotech company reported earnings of $7.8 million, or 12 cents a share, on total sales of $84.1 million. Analysts polled by Thomson First Call were expecting earnings of 17 cents a share on sales of $88.1 million. A year ago the company earned $7 million, or 11 cents a share, on sales of $79.8 million.
Looking ahead, Affymetrix forecast a third-quarter loss of 6 cents a share on sales of $95 million. The earnings forecast includes charges of $17.5 million, or 27 cents a share, but excludes non-cash amortization of about $1 million, or 2 cents a share. Analysts had been expecting earnings of 29 cents a share on sales of $101.7 million. Shares were trading down $10.83 to $46.16.
Manor Care (HCR) rose modestly after the company reported second-quarter earnings that beat forecasts. The operator of nursing homes reported earnings of $37.9 million, or 43 cents a share, on sales of $833.8 million. Excluding items, the company would have earned 48 cents a share. Analysts were expecting earnings of 46 cents a share on sales of $828.8 million. A year ago the company earned $40.1 million, or 45 cents a share, on sales of $799.1 million. In addition to earnings, Manor Care said its board has authorized an additional $300 million for stock repurchases. At the end of the second quarter, the company about $44 million remaining under its previously approved buyback plan. Shares were trading up 5 cents to $36.55.Shares of Beckman Coulter (BEC) fell 15% after the maker of testing instruments posted second-quarter earnings that fell well below expectations and slashed its 2005 guidance. The company reported earnings of $47.7 million, or 73 cents a share, on sales of $618.8 million. Excluding items, the company would have posted earnings of $51.9 million, or 80 cents a share. Analysts were expecting earnings of 92 cents a share on sales of $641.5 million. A year ago the company earned $58.3 million, or 88 cents a share, on sales of $597.3 million.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV